This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Malloy, P. J. Articles by Feldman, D. Search for Related Content PubMed PubMed Citation Articles by Malloy, P. J. Articles by Feldman, D.

The Vitamin D Receptor and the Syndrome of Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets¹

Department of Medicine (P.J.M., D.F.), Stanford University School of Medicine, Stanford, California 94305-5103; and Department of Molecular and Cellular Physiology (J.W.P.), University of Cincinnati, Cincinnati, Ohio 45267

I. The Syndrome of Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets (HVDRR)

A. Historical

B. Clinical features of HVDRR

C. Pathophysiology

D. Alopecia

E. 1,25-Dihydroxyvitamin D [1,25-(OH)₂D] action and HVDRR

II. Vitamin D Physiology

A. Metabolism

B. 1-Hydroxylase deficiency

III. 1,25-Dihydroxyvitamin D Action Mediated by the Vitamin D receptor (VDR)

A. Historical aspects of VDR structure and function

B. The domain structure of the VDR

C. The regulation of gene expression by the VDR

IV. Cellular Basis of HVDRR

A. Studies in cultured skin fibroblasts

B. Studies in other cells

V. The VDR Gene and the Molecular Basis of HVDRR

A. The VDR chromosomal gene

B. The VDR gene promoter

C. Polymorphisms of the VDR gene

VI. HVDRR Mutations Causing the Ligand-Binding Positive Phenotype

A. Initial description of DNA-binding domain (DBD) mutations

B. Characterization of additional DBD mutations

C. Structural analysis of DBD mutations

VII. HVDRR Mutations Causing the Ligand-Binding Negative Phenotype

A. Initial description of ligand-binding domain (LBD) mutations

B. Characterization of additional LBD mutations

C. Structural analysis of LBD mutations

VIII. Additional Mutations In The VDR Gene

A. Hinge region mutations

B. Splice site mutations

C. Major structural mutations

D. Vitamin D resistance without a mutation in the VDR

IX. HVDRR Mouse Model

X. Treatment of HVDRR

A. Vitamin D

B. Calcium

C. Prenatal diagnosis

D. Spontaneous healing of rickets

XI. Analysis, Summary, and Conclusions

This article has been cited by other articles:

				A. L. M. Sutton, X. Zhang, D. R. Dowd, Y. P. Kharode, B. S. Komm, and P. N. MacDonald Semaphorin 3B Is a 1,25-Dihydroxyvitamin D3-Induced Gene in Osteoblasts that Promotes Osteoclastogenesis and Induces Osteopenia in Mice Mol. Endocrinol., June 1, 2008; 22(6): 1370 - 1381. [Abstract] [Full Text] [PDF]

				D. Praslickova, S. Sharif, A. Sarson, M. F. Abdul-Careem, D. Zadworny, A. Kulenkamp, G. Ansah, and U. Kuhnlein Association of a Marker in the Vitamin D Receptor Gene with Marek's Disease Resistance in Poultry Poult. Sci., June 1, 2008; 87(6): 1112 - 1119. [Abstract] [Full Text] [PDF]

				J. Wang, P. J. Malloy, and D. Feldman Interactions of the Vitamin D Receptor with the Corepressor Hairless: ANALYSIS OF HAIRLESS MUTANTS IN ATRICHIA WITH PAPULAR LESIONS J. Biol. Chem., August 31, 2007; 282(35): 25231 - 25239. [Abstract] [Full Text] [PDF]

				L. Cianferotti, M. Cox, K. Skorija, and M. B. Demay Vitamin D receptor is essential for normal keratinocyte stem cell function PNAS, May 29, 2007; 104(22): 9428 - 9433. [Abstract] [Full Text] [PDF]

				D. D. Moore, S. Kato, W. Xie, D. J. Mangelsdorf, D. R. Schmidt, R. Xiao, and S. A. Kliewer International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor {alpha}, Farnesoid X Receptor beta, Liver X Receptor {alpha}, Liver X Receptor beta, and Vitamin D Receptor Pharmacol. Rev., December 1, 2006; 58(4): 742 - 759. [Abstract] [Full Text] [PDF]

				M. B. Meyer, M. Watanuki, S. Kim, N. K. Shevde, and J. W. Pike The Human Transient Receptor Potential Vanilloid Type 6 Distal Promoter Contains Multiple Vitamin D Receptor Binding Sites that Mediate Activation by 1,25-Dihydroxyvitamin D3 in Intestinal Cells Mol. Endocrinol., June 1, 2006; 20(6): 1447 - 1461. [Abstract] [Full Text] [PDF]

				Z. Xie, S. Chang, Y. Oda, and D. D. Bikle Hairless Suppresses Vitamin D Receptor Transactivation in Human Keratinocytes Endocrinology, January 1, 2006; 147(1): 314 - 323. [Abstract] [Full Text] [PDF]

				K. Skorija, M. Cox, J. M. Sisk, D. R. Dowd, P. N. MacDonald, C. C. Thompson, and M. B. Demay Ligand-Independent Actions of the Vitamin D Receptor Maintain Hair Follicle Homeostasis Mol. Endocrinol., April 1, 2005; 19(4): 855 - 862. [Abstract] [Full Text] [PDF]

				L. Schneider, C. El-Yazidi, A. Dace, M. Maraninchi, R. Planells, A. Margotat, and J. Torresani Expression of the 1,25-(OH)2 vitamin D3 receptor gene during the differentiation of mouse Ob17 preadipocytes and cross talk with the thyroid hormone receptor signalling pathway J. Mol. Endocrinol., February 1, 2005; 34(1): 221 - 235. [Abstract] [Full Text] [PDF]

				P. J. Malloy, R. Xu, L. Peng, S. Peleg, A. Al-Ashwal, and D. Feldman Hereditary 1,25-Dihydroxyvitamin D Resistant Rickets due to a Mutation Causing Multiple Defects in Vitamin D Receptor Function Endocrinology, November 1, 2004; 145(11): 5106 - 5114. [Abstract] [Full Text] [PDF]

				J. M. Zarach, G. M. J. Beaudoin III, P. A. Coulombe, and C. C. Thompson The co-repressor hairless has a role in epithelial cell differentiation in the skin Development, September 1, 2004; 131(17): 4189 - 4200. [Abstract] [Full Text] [PDF]

				B.A. Rybicki, M.J. Maliarik, L.M. Poisson, and M.C. Iannuzzi Sarcoidosis and granuloma genes: a family-based study in African-Americans Eur. Respir. J., August 1, 2004; 24(2): 251 - 257. [Abstract] [Full Text] [PDF]

				I. Oakley-Girvan, D. Feldman, T. R. Eccleshall, R. P. Gallagher, A. H. Wu, L. N. Kolonel, J. Halpern, R. R. Balise, D. W. West, R. S. Paffenbarger Jr., et al. Risk of Early-Onset Prostate Cancer in Relation to Germ Line Polymorphisms of the Vitamin D Receptor Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1325 - 1330. [Abstract] [Full Text] [PDF]

				T.-M. Nguyen, M. Lieberherr, J. Fritsch, H. Guillozo, M. L. Alvarez, Z. Fitouri, F. Jehan, and M. Garabedian The Rapid Effects of 1,25-Dihydroxyvitamin D3 Require the Vitamin D Receptor and Influence 24-Hydroxylase Activity: STUDIES IN HUMAN SKIN FIBROBLASTS BEARING VITAMIN D RECEPTOR MUTATIONS J. Biol. Chem., February 27, 2004; 279(9): 7591 - 7597. [Abstract] [Full Text] [PDF]

				B. C. J. van der Eerden, M. Karperien, and J. M. Wit Systemic and Local Regulation of the Growth Plate Endocr. Rev., December 1, 2003; 24(6): 782 - 801. [Abstract] [Full Text] [PDF]

				J.-C. Hsieh, J. M. Sisk, P. W. Jurutka, C. A. Haussler, S. A. Slater, M. R. Haussler, and C. C. Thompson Physical and Functional Interaction between the Vitamin D Receptor and Hairless Corepressor, Two Proteins Required for Hair Cycling J. Biol. Chem., October 3, 2003; 278(40): 38665 - 38674. [Abstract] [Full Text] [PDF]

				J. Welsh, J. A. Wietzke, G. M. Zinser, B. Byrne, K. Smith, and C. J. Narvaez Vitamin D-3 Receptor as a Target for Breast Cancer Prevention J. Nutr., July 1, 2003; 133(7): 2425S - 2433. [Abstract] [Full Text] [PDF]

				D. M. Peehl, A. V. Krishnan, and D. Feldman Pathways Mediating the Growth-Inhibitory Actions of Vitamin D in Prostate Cancer J. Nutr., July 1, 2003; 133(7): 2461S - 2469. [Abstract] [Full Text] [PDF]

				H. Chen, M. Hewison, B. Hu, and J. S. Adams Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: A cause of vitamin D resistance PNAS, May 13, 2003; 100(10): 6109 - 6114. [Abstract] [Full Text] [PDF]

				A. L. M. Sutton and P. N. MacDonald Vitamin D: More Than a "Bone-a-Fide" Hormone Mol. Endocrinol., May 1, 2003; 17(5): 777 - 791. [Abstract] [Full Text] [PDF]

				Y. Xu, A. Shibata, J. E. McNeal, T. A. Stamey, D. Feldman, and D. M. Peehl Vitamin D Receptor Start Codon Polymorphism (FokI) and Prostate Cancer Progression Cancer Epidemiol. Biomarkers Prev., January 1, 2003; 12(1): 23 - 27. [Abstract] [Full Text] [PDF]

				P. J. Malloy, R. Xu, L. Peng, P. A. Clark, and D. Feldman A Novel Mutation in Helix 12 of the Vitamin D Receptor Impairs Coactivator Interaction and Causes Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets without Alopecia Mol. Endocrinol., November 1, 2002; 16(11): 2538 - 2546. [Abstract] [Full Text] [PDF]

				R. G. Erben, D. W. Soegiarto, K. Weber, U. Zeitz, M. Lieberherr, R. Gniadecki, G. Moller, J. Adamski, and R. Balling Deletion of Deoxyribonucleic Acid Binding Domain of the Vitamin D Receptor Abrogates Genomic and Nongenomic Functions of Vitamin D Mol. Endocrinol., July 1, 2002; 16(7): 1524 - 1537. [Abstract] [Full Text] [PDF]

				S. Ando, N. J. Sarlis, J. Krishnan, X. Feng, S. Refetoff, M. Q. Zhang, E. H. Oldfield, and P. M. Yen Aberrant Alternative Splicing of Thyroid Hormone Receptor in a TSH-Secreting Pituitary Tumor Is A Mechanism for Hormone Resistance Mol. Endocrinol., September 1, 2001; 15(9): 1529 - 1538. [Abstract] [Full Text] [PDF]

				K. L. Sunn, T.-A. Cock, L. A. Crofts, J. A. Eisman, and E. M. Gardiner Novel N-Terminal Variant of Human VDR Mol. Endocrinol., September 1, 2001; 15(9): 1599 - 1609. [Abstract] [Full Text] [PDF]

				Y. C. Li, M. J. G. Bolt, L.-P. Cao, and M. D. Sitrin Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism Am J Physiol Endocrinol Metab, September 1, 2001; 281(3): E558 - E564. [Abstract] [Full Text] [PDF]

				M Li, H Chiba, X Warot, N Messaddeq, C Gerard, P Chambon, and D Metzger RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations Development, January 3, 2001; 128(5): 675 - 688. [Abstract] [PDF]

				S. J. Marx Hyperparathyroid and Hypoparathyroid Disorders N. Engl. J. Med., December 21, 2000; 343(25): 1863 - 1875. [Full Text] [PDF]

				Y.-Y. Liu, C. Nguyen, and S. Peleg Regulation of Ligand-Induced Heterodimerization and Coactivator Interaction by the Activation Function-2 Domain of the Vitamin D Receptor Mol. Endocrinol., November 1, 2000; 14(11): 1776 - 1787. [Abstract] [Full Text]

				A. Slominski and J. Wortsman Neuroendocrinology of the Skin Endocr. Rev., October 1, 2000; 21(5): 457 - 487. [Abstract] [Full Text]

				S. Swami, A. V. Krishnan, and D. Feldman 1{{alpha}},25-Dihydroxyvitamin D3 Down-Regulates Estrogen Receptor Abundance and Suppresses Estrogen Actions in MCF-7 Human Breast Cancer Cells Clin. Cancer Res., August 1, 2000; 6(8): 3371 - 3379. [Abstract] [Full Text]

				Y. Sakai and M. B. Demay Evaluation of Keratinocyte Proliferation and Differentiation in Vitamin D Receptor Knockout Mice Endocrinology, June 1, 2000; 141(6): 2043 - 2049. [Abstract] [Full Text] [PDF]

				S. A. Gardezi, C. Nguyen, P. J. Malloy, G. H. Posner, D. Feldman, and S. Peleg A Rationale for Treatment of Hereditary Vitamin D-resistant Rickets with Analogs of 1alpha ,25-Dihydroxyvitamin D3 J. Biol. Chem., July 27, 2001; 276(31): 29148 - 29156. [Abstract] [Full Text] [PDF]